Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: safety and immunogenicity of a phase 1/2 clinical trial. [electronic resource]
Producer: 20100203Description: 840-8 p. digitalISSN:- 1873-2518
- Adjuvants, Immunologic -- administration & dosage
- Adolescent
- Adult
- Antibodies, Neutralizing -- blood
- Antibodies, Viral -- blood
- Drug-Related Side Effects and Adverse Reactions
- Female
- Hemagglutination Inhibition Tests
- Hemagglutinins, Viral -- immunology
- Humans
- Immunization, Secondary
- Influenza A Virus, H5N1 Subtype -- immunology
- Influenza Vaccines -- administration & dosage
- Influenza, Human -- prevention & control
- Injections, Intramuscular
- Male
- Polysorbates -- administration & dosage
- Squalene -- administration & dosage
- Vaccination -- methods
- Vaccines, Subunit -- administration & dosage
- Young Adult
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.